Mutated MYD88 zygosity and CXCR4 mutation status are important determinants of ibrutinib response and progression free survival in Waldenstrom's macroglobulinemia Meeting Abstract
| Authors: | Treon, S. P.; Tsakmaklis, N.; Meid, K.; Yang, G.; Chen, J. J. G.; Liu, X.; Chen, J.; Demos, M.; Patterson, C. J.; Dubeau, T.; Gustine, J.; Castillo, J. J.; Advani, R. H.; Palomba, M. L.; Xu, L.; Hunter, Z. |
| Abstract Title: | Mutated MYD88 zygosity and CXCR4 mutation status are important determinants of ibrutinib response and progression free survival in Waldenstrom's macroglobulinemia |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452307163 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.2984.2984 |
| Notes: | Meeting Abstract: 2984 -- San Diego, CA -- Source: Wos |
